AMETEK Acquires Paragon Medical from American Securities for ~$1.9B

Getinge Acquires Paragonix Technologies

August 22, 2024

Medical Devices

Getinge has completed the acquisition of Paragonix Technologies, a U.S. developer of organ preservation devices and transplant logistics services, for an estimated total consideration of USD 477 million (including earn-outs). The deal will make Paragonix a wholly owned subsidiary of Getinge and is intended to expand Getinge's transplant product portfolio and bring Paragonix's technologies to new global markets.

Paragon 28 Acquires Assets of Additive Orthopaedics

June 1, 2021

Medical Devices

Paragon 28, Inc. acquired the product lines and related assets of Additive Orthopaedics, including the FDA‑cleared 3D‑printed patient‑specific talus spacer and an integrated cloud‑based pre‑operative surgical planning application. The acquisition expands Paragon 28’s foot‑and‑ankle product offering and accelerates its strategy to integrate smart tools, AI and advanced technologies to improve patient outcomes.

Aptean Acquires Paragon Software Systems

March 5, 2020

Software

Aptean, a global provider of industry-specific enterprise software, has acquired UK-based Paragon Software Systems, a specialist in transportation management, routing and scheduling solutions. The deal expands Aptean’s logistics and route-optimization capabilities and furthers its presence in the European market, adding Paragon’s installed base and customers in food & beverage, retail, distribution and pharmaceutical sectors.

Peak Rock Capital Affiliate Acquires Paragon Healthcare, Inc.

September 15, 2020

Healthcare Services

An affiliate of Peak Rock Capital completed the acquisition of Paragon Healthcare, Inc., a provider of ambulatory and home infusion services and specialty pharmacy. Peak Rock said it will partner with Paragon's management to support geographic expansion and continued growth through organic initiatives and strategic acquisitions.

Catalent Acquires Paragon Bioservices for $1.2 Billion

May 20, 2019

Biotechnology

Catalent, Inc. completed the $1.2 billion acquisition of Paragon Bioservices, Inc., a viral vector development and manufacturing partner for gene therapies, expanding Catalent’s biologics and gene therapy capabilities. Paragon’s Baltimore-area facilities and ~380 employees will join Catalent’s global biologics platform, while Catalent secured financing including incremental term loans and a convertible preferred issuance to Leonard Green & Partners to support the transaction.

Elevance Health Acquires Paragon Healthcare

March 11, 2024

Healthcare Services

Elevance Health has closed its acquisition of Plano, Texas–based Paragon Healthcare, an infusion services and drug therapy provider operating more than 40 ambulatory infusion centers and serving over 35,000 patients. Paragon will operate under Elevance’s CarelonRx pharmacy services segment to expand access to specialty medications and scale infusion capabilities; financial terms were not disclosed (Axios reported the purchase may exceed $1 billion).